Mandate

Vinge advises Hellman & Friedman in connection with the acquisition of Nets A/S and its Swedish subsidiary DIBS Payment Services AB

February 07, 2018 Banking and Finance

Vinge has advised the US private equity company Hellman & Friedman in connection with the acquisition of the listed Danish payment services company, Nets A/S.

The takeover offer for Nets A/S is Europe’s largest for several years and amounts to DKK 33.1 billion. The final approval from the shareholders of Nets A/S shows that the takeover offer has been accepted by owners holding approximately 94 per cent of the share capital and the votes in Nets A/S.

The Danish company Nets A/S is a world leading supplier of digital payment services and is listed on the Copenhagen Stock Exchange. Nets A/S is also indirectly owned by the Swedish e money institute DIBS Payment Services AB, and thus the acquisition and the change of ownership is conditional upon prior approval of the Swedish Financial Supervisory Authority. The Swedish Financial Supervisory Authority has recently provided such approval in respect of the transaction and approvals have already been received from the Danish, Norwegian and Finnish competent authorities.

Vinge’s team consisted of Emma Stuart Beck (responsible partner), partner Fredrik Wilkens, associates Caroline Krassén, Henrik Schön, Malin Haag, Lave Nilsson and Carolina Sandell. Partner Louise Brorsson Salomon and associate Linn Adelwald advised on financing issues.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026